Impact of Antibody Effector Function Diversity on Antiviral Activity In Situ — GEORGIA Doris TOMARAS (DUKE UNIVERSITY)
ABSTRACT_Overall Preventing HIV-1 acquisition and extinguishing virus replication is a key goal for vaccine and immunoprophylaxis strategies. Diverse antibody (Ab) Fc receptor (FcR)-mediated functions
| Project title | Impact of Antibody Effector Function Diversity on Antiviral Activity In Situ |
|---|---|
| Project number | 5P01AI162242-02 |
| PI name | GEORGIA Doris TOMARAS |
| Institution | DUKE UNIVERSITY |
| Funding mechanism | P01 |
| Agency | NIAID |
| Award amount | $4.26M |
| Fiscal year | 2022 |
| Project start | 2021-08-25T00:00:00 |
| Project end | 2026-07-31T00:00:00 |
| Abstract | ABSTRACT_Overall Preventing HIV-1 acquisition and extinguishing virus replication is a key goal for vaccine and immunoprophylaxis strategies. Diverse antibody (Ab) Fc receptor (FcR)-mediated functions |
| Key terms | <AIDS><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immuno-Deficiency S |
$799/mo
Try GrantRadar →